AMRAX
Price
$6.00
Change
-$0.01 (-0.17%)
Updated
Apr 17 closing price
Net Assets
17.63M
VIGRX
Price
$181.21
Change
+$0.19 (+0.10%)
Updated
Apr 17 closing price
Net Assets
260.76B
Ad is loading...

AMRAX vs VIGRX

Header iconAMRAX vs VIGRX Comparison
Open Charts AMRAX vs VIGRXBanner chart's image
American Growth One A
Price$6.00
Change-$0.01 (-0.17%)
VolumeN/A
Net Assets17.63M
Vanguard Growth Index Investor
Price$181.21
Change+$0.19 (+0.10%)
VolumeN/A
Net Assets260.76B
AMRAX vs VIGRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AMRAX vs. VIGRX commentary
Apr 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMRAX is a Buy and VIGRX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VIGRX has more cash in the bank: 261B vs. AMRAX (17.6M). VIGRX pays higher dividends than AMRAX: VIGRX (0.39) vs AMRAX (0.00). AMRAX was incepted earlier than VIGRX: AMRAX (29 years) vs VIGRX (32 years). AMRAX (4.63) is less costly to investors than VIGRX (0.17). VIGRX is a more actively managed with annual turnover of: 5.00 vs. AMRAX (4.00). AMRAX has a lower initial minimum investment than VIGRX: AMRAX (0) vs VIGRX (3000). VIGRX annual gain was more profitable for investors over the last year : 6.01 vs. AMRAX (-6.53). VIGRX return over 5 years is better than : 99.21 vs. AMRAX (5.25).
AMRAXVIGRXAMRAX / VIGRX
Total Expense Ratio4.630.172,724%
Annual Report Gross Expense Ratio4.630.172,724%
Fund Existence29 years32 years-
Gain YTD-9.895-14.32669%
Front Load6%N/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets17.6M261B0%
Annual Yield % from dividends0.000.39-
Returns for 1 year-6.536.01-109%
Returns for 3 years-7.4030.33-24%
Returns for 5 years5.2599.215%
Returns for 10 years37.21223.8417%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RCKT6.330.18
+2.93%
Rocket Pharmaceuticals
OVV33.820.72
+2.18%
Ovintiv
USAC25.220.29
+1.16%
USA Compression Partners LP
UNB31.340.35
+1.13%
Union Bankshares
VVOS2.100.02
+0.96%
Vivos Therapeutics